Clinical predictors of overall survival in very elderly meningioma patients: a surveillance, epidemiology, and end results (SEER) database analysis

被引:0
作者
Reddy, Sai Chandan [1 ]
Mao, Yuncong [1 ]
Gendreau, Julian [1 ]
Ahmed, A. Karim [1 ]
Mukherjee, Debraj [1 ]
机构
[1] Johns Hopkins Univ, Dept Neurol Surg, Sch Med, 1800 Orleans St, Baltimore, MD 21218 USA
关键词
Meningioma; Survival; Very elderly; Surgery; SEER; SCORING SYSTEM GSS; RESECTION; OUTCOMES; RISK;
D O I
10.1007/s11060-025-04982-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveSurgical resection is the gold standard of management for symptomatic intracranial meningiomas. However, surgical intervention may be contraindicated in very elderly patients. In this study, we assessed the survival outcomes for elderly and very elderly patients and the impact of surgical intervention [e.g., subtotal resection (STR) and gross total resection (GTR)] and radiotherapy (RT). MethodsThe Surveillance, Epidemiology, and End Results (SEER) database was queried to identify all patients >= 65 years of age diagnosed with intracranial meningiomas between 2000 and 2020. Baseline demographics, clinical characteristics, and survival outcomes were compared between elderly (65-79 years) and very elderly (80 + years) patients. Results4,052 intracranial meningioma patients were identified- 3,462 elderly patients and 590 very elderly patients. Very elderly patients were less likely to undergo GTR compared to elderly patients (OR: 0.756, 95% CI: 0.631-0.905, p = 0.002) and less likely to receive RT (OR: 0.441, 95% CI: 0.294-0.642, p < 0.001). Achievement of GTR in very elderly patients did not decrease the risk of death (HR: 1.003, 95% CI: 0.682-1.475, p = 0.987). However, RT was associated with decreased risk of death in very elderly patients (HR: 0.212, 95% CI: 0.052-0.860, p = 0.030). ConclusionIn this retrospective study, we found pursual of aggressive surgical intervention in very elderly patients was not associated with increased mortality. Despite very elderly patients being much less likely to be prescribed radiotherapy, the administration of RT significantly increased overall survival, suggesting a greater role for radiotherapy in managing intracranial meningiomas in the very elderly population.
引用
收藏
页码:439 / 447
页数:9
相关论文
共 41 条
  • [1] Ostrom Q.T., Patil N., Cioffi G., Waite K., Kruchko C., Barnholtz-Sloan J.S., CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2013–2017, Neurooncology, 22, p1, pp. iv1-iv96, (2020)
  • [2] Cohen-Inbar O., Geriatric brain tumor management part I: meningioma, J Clin Neurosci, 67, pp. 5-9, (2019)
  • [3] Cohen-Inbar O., Lee C., Schlesinger D., Xu Z., Sheehan J.P., The geriatric scoring system (GSS) for risk stratification in meningioma patients as a predictor of outcome in patients treated with radiosurgery, World Neurosurg, 87, pp. 431-438, (2016)
  • [4] Cohen-Inbar O., Sviri G.E., Soustiel J.F., Zaaroor M., The geriatric scoring system (GSS) in meningioma patients—validation, Acta Neurochir, 153, 7, pp. 1501-1508, (2011)
  • [5] Amoo M., Henry J., Farrell M., Javadpour M., Meningioma in the elderly, Neuro-Oncology Adv, 5, Supplement1, pp. i13-i25, (2023)
  • [6] Achey R.L., Gittleman H., Schroer J., Et al., Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005–2015, using the central brain tumor registry of the united States, Neurooncology, 21, 3, pp. 380-391, (2019)
  • [7] Petersen R.C., Lopez O., Armstrong M.J., Getchius T.S.D., Ganguli M., Gloss D., Gronseth G.S., Marson D., Pringsheim T., Day G.S., Sager M., Stevens J., Rae-Grant A., Practice guideline update summary: mild cognitive impairment, Neurology, 90, 3, pp. 126-135, (2018)
  • [8] Rydzewski N.R., Lesniak M.S., Chandler J.P., Kalapurakal J.A., Pollom E., Tate M.C., Bloch O., Kruser T., Dalal P., Sachdev S., Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma, Cancer, 124, 4, pp. 734-742, (2018)
  • [9] Goldbrunner R., Stavrinou P., Jenkinson M.D., Sahm F., Mawrin C., Weber D.C., Preusser M., Minniti G., Lund-Johansen M., Lefranc F., Houdart E., Sallabanda K., Le Rhun E., Nieuwenhuizen D., Tabatabai G., Soffietti R., Weller M., EANO guideline on the diagnosis and management of meningiomas, Neurooncology, 23, 11, pp. 1821-1834, (2021)
  • [10] van Alkemade H., de Leau M., Dieleman E.M.T., Kardaun J.W.P.F., van Os R., Vandertop W.P., van Furth W.R., Stalpers L.J.A., Impaired survival and long-term neurological problems in benign meningioma, Neurooncology, 14, 5, pp. 658-666, (2012)